TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference

Rhea-AI Summary

TELA Bio, Inc. (NASDAQ: TELA) to participate in Piper Sandler’s 35th Annual Healthcare Conference. TELA's management will present at the conference on November 30th, 2023, focusing on innovative soft-tissue reconstruction solutions. Interested parties can access the webcast at ir.telabio.com.

MALVERN, Pa., Nov. 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today announced that the Company will participate in Piper Sandler’s 35^th Annual Healthcare Conference.

TELA’s management is scheduled to present at Piper Sandler’s 35^th Annual Healthcare Conference at 11:00 am ET on November 30^th, 2023. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@telabio.com    

 

FAQ

What is TELA Bio, Inc. participating in?

TELA Bio, Inc. is participating in Piper Sandler’s 35th Annual Healthcare Conference.

When will TELA's management present at the conference?

TELA's management is scheduled to present at 11:00 am ET on November 30th, 2023.

Where can interested parties access the webcast?

Interested parties can access the live and archived webcast at ir.telabio.com.